Upgrade to SI Premium - Free Trial

Bemis (BMS)

57.25 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- M&A (3/31/19 *Est)

Latest Headlines

Arcus Biosciences partners with Bristol Myers Squibb on kidney cancer trial June 3, 2026 8:01 AM - StreetInsider Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer June 3, 2026 8:00 AM - BizWire Bristol Myers Squibb partners with Anthropic to deploy AI across operations May 20, 2026 6:59 AM - StreetInsider Bristol Myers Squibb Announces Strategic Agreement with Anthropic to Position Claude Enterprise as the Shared Intelligence Platform Across Its Global Operations May 20, 2026 6:59 AM - BizWire Full Article List